Skip to content

The Determination of the Effect of Volatile Anesthetics on Leukocyte Function ex Vivo

The Determination of the Effect of Volatile Anesthetics on Leukocyte Function ex Vivo

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02207842
Enrollment
41
Registered
2014-08-04
Start date
2014-11-30
Completion date
2017-01-31
Last updated
2017-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Leukocyte Function

Brief summary

One of the most common side effects of a surgical procedure is infection. In order to lower the number of infections that occur after surgery, it is important for physicians to know how medications used during surgery affect the way the body fights infection. Often, when anesthesiologists are helping people go to sleep before surgery they give people medications known as volatile anesthetics. Volatile anesthetics are medications that can change from a liquid or solid to a gas very easily. Some studies suggest that these types of medications may change the way white blood cells work in the body. Changing the way white blood cells work could possibly increase the person's risk of infection after their surgery or weaken their body's ability to fight infections. The goal of this research study is to learn about how volatile anesthesia medications change the way white blood cells work in people having anesthesia for cardiac procedures. To do this, investigators will examine the function of while blood cells in the laboratory based setting.

Interventions

None listed

Sponsors

Boston Children's Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
12 Months to No maximum
Healthy volunteers
No

Inclusion criteria

* Male and female patients * greater than or equal to 12 months of age * scheduled for a cardiac catheterization, cardiac surgery, or cardiac MRI

Exclusion criteria

* known underlying hematological disorder * known oncological disorder * patients who do not require preoperative laboratory testing

Design outcomes

Primary

MeasureTime frameDescription
Leukocyte function under anesthesiaup to 12 monthsThe study will evaluate ex vivo leukocyte function by testing leukocyte activation, TNF-a production, and phagocytic function in the laboratory.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026